Related Experiment Video
Updated: Aug 24, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Understanding blood donor deferrals in Colombia: a seven-year study (2017-2023) from a regional blood bank
Johan Bula-Viecco1, Hernán Argote-Berdugo1, Ricardo Ávila de la Hoz1
1Banco Nacional de Sangre, Barranquilla, Colombia.
Insights
Blood donor deferral rates in Barranquilla were significantly lower than national averages. Anemia and behavioral risks were the primary reasons for deferral, with notable differences based on sex.
Area of Science:
- Hematology
- Public Health
- Epidemiology
Background:
- Global blood donor deferral rates average 13%, impacting blood availability.
- Limited data exists on deferral patterns in Latin America.
- Understanding deferral causes is crucial for public health needs.
Purpose of the Study:
- To characterize blood donor deferrals in Barranquilla, Colombia.
- To identify demographic and temporal factors influencing deferral causes and types.
- To compare local deferral rates with national and international data.
Main Methods:
- Observational, analytical, retrospective study (2017-2023).
- Analysis of age, sex, deferral type, and reasons for deferral.
- Multivariable logistic regression models used for analysis.
Main Results:
- A low deferral rate of 2.8% was observed, five times lower than national estimates.
- Anemia (38.3%) and behavioral risk factors (37.9%) were the leading deferral causes.
- Female sex was linked to higher anemia deferral but lower behavioral risk and permanent deferral.
Conclusions:
- Barranquilla's blood donor deferral rates are notably lower than reported national and international figures.
- Anemia and behavioral risks are the predominant reasons for blood donor deferral in this region.
- Sex is a significant factor associated with specific deferral reasons and types.
Introduction:
The World Health Organization's Global Status Report on Blood Safety and Availability 2021 documented a median donor deferral rate of 13% (range: 1-67%). Deferral reduces blood availability and may indicate unmet public health needs. Given the scarcity of data from Latin America, this study aimed to characterize blood donor deferrals and identify demographic and temporal factors associated with the main causes and types of deferral at a regional blood bank in Barranquilla (Colombia).
Methods:
We conducted an observational, analytical, retrospective study of deferred blood donors in Barranquilla from 2017 to 2023. Age, sex, deferral type, and reasons for deferral were analyzed using multivariable logistic regression models.
Results:
During the study period, 319,131 individuals presented as potential donors, of whom 8432 were deferred (2.8%; IQR: 2.1-3.0). This deferral rate was 5 times lower than national estimates (13.9%; IQR: 6.5-21.6). Of deferred donors, 12.5% were permanent and 87.5% temporary. Mean age was 33.9 ± 11.4 years; 18-44-year-olds accounted for 81.0%. The leading cause of deferral was anemia (38.3%), followed by behavioral risk factors (37.9%). Multivariable analysis showed that female sex was associated with deferral due to anemia [aOR: 12.04 (95% CI: 10.72-13.52;p < 0.001)], whereas it was associated with lower odds of behavioral risk-related deferral [aOR: 0.13 (95% CI: 0.12-0.15; p < 0.001)] and permanent deferral [aOR: 0.28 (95% CI: 0.24-0.32; p < 0.001)].
Conclusion:
Deferral rates in this institution were lower than national and international reports, with anemia and behavioral risks as the leading causes.
More Related Videos
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...